scispace - formally typeset
Search or ask a question
Institution

University of Luxembourg

EducationLuxembourg, Luxembourg
About: University of Luxembourg is a education organization based out in Luxembourg, Luxembourg. It is known for research contribution in the topics: Context (language use) & Computer science. The organization has 4744 authors who have published 22175 publications receiving 381824 citations.


Papers
More filters
Journal ArticleDOI
Ruth Chia1, Marya S. Sabir, Sara Bandres-Ciga1, Sara Saez-Atienzar1  +163 moreInstitutions (55)
TL;DR: This article performed whole-genome sequencing in large cohorts of Lewy body dementia (LBD) cases and neurologically healthy controls to study the genetic architecture of this understudied form of dementia, and to generate a resource for the scientific community.
Abstract: The genetic basis of Lewy body dementia (LBD) is not well understood. Here, we performed whole-genome sequencing in large cohorts of LBD cases and neurologically healthy controls to study the genetic architecture of this understudied form of dementia, and to generate a resource for the scientific community. Genome-wide association analysis identified five independent risk loci, whereas genome-wide gene-aggregation tests implicated mutations in the gene GBA. Genetic risk scores demonstrate that LBD shares risk profiles and pathways with Alzheimer's disease and Parkinson's disease, providing a deeper molecular understanding of the complex genetic architecture of this age-related neurodegenerative condition.

124 citations

Journal ArticleDOI
TL;DR: It is shown that PGC-1α expression is positively correlated with that of the glutamine pathway in ERBB2+ breast cancer patients, and high expression of this pathway is associated with reduced patient survival, suggesting that targeting glutamine metabolism may have therapeutic potential in the treatment of ER BB2- breast cancer.
Abstract: Glutamine metabolism is a central metabolic pathway in cancer. Recently, reductive carboxylation of glutamine for lipogenesis has been shown to constitute a key anabolic route in cancer cells. However, little is known regarding central regulators of the various glutamine metabolic pathways in cancer cells. The impact of PGC-1α and ERRα on glutamine enzyme expression was assessed in ERBB2+ breast cancer cell lines with quantitative RT-PCR, chromatin immunoprecipitation, and immunoblotting experiments. Glutamine flux was quantified using 13C-labeled glutamine and GC/MS analyses. Functional assays for lipogenesis were performed using 14C-labeled glutamine. The expression of glutamine metabolism genes in breast cancer patients was determined by bioinformatics analyses using The Cancer Genome Atlas. We show that the transcriptional coactivator PGC-1α, along with the transcription factor ERRα, is a positive regulator of the expression of glutamine metabolism genes in ERBB2+ breast cancer. Indeed, ERBB2+ breast cancer cells with increased expression of PGC-1α display elevated expression of glutamine metabolism genes. Furthermore, ERBB2+ breast cancer cells with reduced expression of PGC-1α or when treated with C29, a pharmacological inhibitor of ERRα, exhibit diminished expression of glutamine metabolism genes. The biological relevance of the control of glutamine metabolism genes by the PGC-1α/ERRα axis is demonstrated by consequent regulation of glutamine flux through the citric acid cycle. PGC-1α and ERRα regulate both the canonical citric acid cycle (forward) and the reductive carboxylation (reverse) fluxes; the latter can be used to support de novo lipogenesis reactions, most notably in hypoxic conditions. Importantly, murine and human ERBB2+ cells lines display a significant dependence on glutamine availability for their growth. Finally, we show that PGC-1α expression is positively correlated with that of the glutamine pathway in ERBB2+ breast cancer patients, and high expression of this pathway is associated with reduced patient survival. These data reveal that the PGC-1α/ERRα axis is a central regulator of glutamine metabolism in ERBB2+ breast cancer. This novel regulatory link, as well as the marked reduction in patient survival time associated with increased glutamine pathway gene expression, suggests that targeting glutamine metabolism may have therapeutic potential in the treatment of ERBB2+ breast cancer.

124 citations

Posted Content
TL;DR: The authors used immigrants' age of entry as a proxy for where they acquired their education and proposed alternative brain drain measures that exclude immigrants who arrived before ages 12, 18, and 22.
Abstract: Recent data on international migration of skilled workers define skilled migrants by education level without distinguishing whether they acquired their education in the home or the host country. This article uses immigrants' age of entry as a proxy for where they acquired their education. Data on age of entry are available from a subset of receiving countries that together represent 77 percent of total skilled immigration to countries of the OECD (Organization for Economic Co-operation and Development). Using these data and a simple gravity model to estimate the age-of-entry structure of the remaining 23 percent, alternative brain drain measures are proposed that exclude immigrants who arrived before ages 12, 18, and 22.

124 citations

Journal ArticleDOI
TL;DR: The genetic and functional studies of novel disease-associated variants in the mortalin gene define a loss of mortalin function, which causes impaired mitochondrial function and dynamics, and underscores the concept of impaired mitochondrial protein quality control in PD.
Abstract: The mitochondrial chaperone mortalin has been linked to neurodegeneration in Parkinson's disease (PD) based on reduced protein levels in affected brain regions of PD patients and its interaction with the PD-associated protein DJ-1. Recently, two amino acid exchanges in the ATPase domain (R126W) and the substrate-binding domain (P509S) of mortalin were identified in Spanish PD patients. Here, we identified a separate and novel variant (A476T) in the substrate-binding domain of mortalin in German PD patients. To define a potential role as a susceptibility factor in PD, we characterized the functions of all three variants in different cellular models. In vitro import assays revealed normal targeting of all mortalin variants. In neuronal and non-neuronal human cell lines, the disease-associated variants caused a mitochondrial phenotype of increased reactive oxygen species and reduced mitochondrial membrane potential, which were exacerbated upon proteolytic stress. These functional impairments correspond with characteristic alterations of the mitochondrial network in cells overexpressing mutant mortalin compared with wild-type (wt), which were confirmed in fibroblasts from a carrier of the A476T variant. In line with a loss of function hypothesis, knockdown of mortalin in human cells caused impaired mitochondrial function that was rescued by wt mortalin, but not by the variants. Our genetic and functional studies of novel disease-associated variants in the mortalin gene define a loss of mortalin function, which causes impaired mitochondrial function and dynamics. Our results support the role of this mitochondrial chaperone in neurodegeneration and underscore the concept of impaired mitochondrial protein quality control in PD.

124 citations

Journal ArticleDOI
TL;DR: A review of the current state-of-the-art approaches for modeling molecular crystals can be found in this paper, where the main focus has been on calculating stabilities and structures without considering thermal contributions.
Abstract: The understanding of the structure, stability, and response properties of molecular crystals at finite temperature and pressure is crucial for the field of crystal engineering and their application. For a long time, the field of crystal-structure prediction and modeling of molecular crystals has been dominated by classical mechanistic force-field methods. However, due to increasing computational power and the development of more sophisticated quantum-mechanical approximations, first-principles approaches based on density functional theory can now be applied to practically relevant molecular crystals. The broad transferability of first-principles methods is especially imperative for polymorphic molecular crystals. This review highlights the current status of modeling molecular crystals from first principles. We give an overview of current state-of-the-art approaches and discuss in detail the main challenges and necessary approximations. So far, the main focus in this field has been on calculating stabilities and structures without considering thermal contributions. We discuss techniques that allow one to include thermal effects at a first-principles level in the harmonic or quasi-harmonic approximation, and that are already applicable to realistic systems, or will be in the near future. Furthermore, this review also discusses how to calculate vibrational and elastic properties. Finally, we present a perspective on future uses of first-principles calculations for modeling molecular crystals and summarize the many remaining challenges in this field. WIREs Comput Mol Sci 2017, 7:e1294. doi: 10.1002/wcms.1294 For further resources related to this article, please visit the WIREs website.

124 citations


Authors

Showing all 4893 results

NameH-indexPapersCitations
Jun Wang1661093141621
Leroy Hood158853128452
Andreas Heinz108107845002
Philippe Dubois101109848086
John W. Berry9735152470
Michael Müller9133326237
Bart Preneel8284425572
Bjorn Ottersten81105828359
Sander Kersten7924623985
Alexandre Tkatchenko7727126863
Rudi Balling7523819529
Lionel C. Briand7538024519
Min Wang7271619197
Stephen H. Friend7018453422
Ekhard K. H. Salje7058119938
Network Information
Related Institutions (5)
Royal Institute of Technology
68.4K papers, 1.9M citations

90% related

University of York
56.9K papers, 2.4M citations

90% related

ETH Zurich
122.4K papers, 5.1M citations

90% related

Carnegie Mellon University
104.3K papers, 5.9M citations

90% related

École Polytechnique Fédérale de Lausanne
98.2K papers, 4.3M citations

90% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202360
2022250
20211,671
20201,776
20191,710
20181,663